Related references
Note: Only part of the references are listed.Expression of functional cannabinoid CB2 receptor in VTA dopamine neurons in rats
Hai-Ying Zhang et al.
ADDICTION BIOLOGY (2017)
PET imaging of cannabinoid type 2 receptors with [11C]A-836339 did not evidence changes following neuroinflammation in rats
Geraldine Pottier et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2017)
Cannabinoid receptor type 2 (CB2) as one of the candidate genes in human carotid plaque imaging: Evaluation of the novel radiotracer [11C] RS-016 targeting CB2 in atherosclerosis
Romana Meletta et al.
NUCLEAR MEDICINE AND BIOLOGY (2017)
Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer's disease
Rawaha Ahmad et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Development of a High-Affinity PET Radioligand for Imaging Cannabinoid Subtype 2 Receptor
Rares-Petru Moldovan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Discovery of a fluorinated 4-oxo-quinoline derivative as a potential positron emission tomography radiotracer for imaging cannabinoid receptor type 2
Roger Slavik et al.
JOURNAL OF NEUROCHEMISTRY (2016)
Cannabinoid Type 2 Receptors Mediate a Cell Type-Specific Plasticity in the Hippocampus
A. Vanessa Stempel et al.
NEURON (2016)
Potential of the cannabinoid CB2 receptor as a pharmacological target against inflammation in Parkinson's disease
Yolanda Gomez-Galvez et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2016)
Synthesis, Biodistribution and In vitro Evaluation of Brain Permeable High Affinity Type 2 Cannabinoid Receptor Agonists [11C]MA2 and [18F]MA3
Muneer Ahamed et al.
FRONTIERS IN NEUROSCIENCE (2016)
CB2 Cannabinoid Receptor As Potential Target against Alzheimer's Disease
Ester Aso et al.
FRONTIERS IN NEUROSCIENCE (2016)
Synthesis, radiolabeling and evaluation of novel 4-oxo-quinoline derivatives as PET tracers for imaging cannabinoid type 2 receptor
Roger Slavik et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Synthesis, in vitro and in vivo evaluation of 1,3,5-triazines as cannabinoid CB2 receptor agonists
Sari Yrjola et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Differential upregulation of the cannabinoid CB2 receptor in neurotoxic and inflammation-driven rat models of Parkinson's disease
Ruth M. Concannon et al.
EXPERIMENTAL NEUROLOGY (2015)
Discovery of a High Affinity and Selective Pyridine Analog as a Potential Positron Emission Tomography Imaging Agent for Cannabinoid Type 2 Receptor
Roger Slavik et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Cannabinoid CB2 Receptors in a Mouse Model of Aβ Amyloidosis: Immunohistochemical Analysis and Suitability as a PET Biomarker of Neuroinflammation
Alena V. Savonenko et al.
PLOS ONE (2015)
Synthesis and preliminary evaluation of a new fluorine-18 labelled triazine derivative for PET imaging of cannabinoid CB2 receptor
Laurent Hortala et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Activation of GPR18 by cannabinoid compounds: a tale of biased agonism
Linda Console-Bram et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Synthesis and Preliminary Evaluation of a 2-Oxoquinoline Carboxylic Acid Derivative for PET Imaging the Cannabinoid Type 2 Receptor
Linjing Mu et al.
PHARMACEUTICALS (2014)
Recent Development of CB2 Selective and Peripheral CB1/CB2 Cannabinoid Receptor Ligands
Tapio Nevalainen
CURRENT MEDICINAL CHEMISTRY (2013)
Radiolabeling and in vitro/in vivo evaluation of N-(1-adamantyl)-8-methoxy-4-oxo-1-phenyl-1,4-dihydroquinoline-3-carboxamide as a PET probe for imaging cannabinoid type 2 receptor
Linjing Mu et al.
JOURNAL OF NEUROCHEMISTRY (2013)
Whole-Body Biodistribution and Radiation Dosimetry of the Cannabinoid Type 2 Receptor Ligand [11C]-NE40 in Healthy Subjects
Rawaha Ahmad et al.
MOLECULAR IMAGING AND BIOLOGY (2013)
GPR18 in microglia: implications for the CNS and endocannabinoid system signalling
D. McHugh
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Small-animal PET imaging of the type 1 and type 2 cannabinoid receptors in a photothrombotic stroke model
Caroline Vandeputte et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
Preclinical evaluation of [11C]NE40, a type 2 cannabinoid receptor PET tracer
Nele Evens et al.
NUCLEAR MEDICINE AND BIOLOGY (2012)
Cannabinoid Type 2 Receptor Activation Downregulates Stroke-Induced Classic and Alternative Brain Macrophage/Microglial Activation Concomitant to Neuroprotection
Juan G. Zarruk et al.
STROKE (2012)
Synthesis, in vitro and in vivo evaluation of fluorine-18 labelled FE-GW405833 as a PET tracer for type 2 cannabinoid receptor imaging
Nele Evens et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ9-THCV in animal models of Parkinson's disease
C. Garcia et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
A PET Brain Reporter Gene System Based on Type 2 Cannabinoid Receptors
Caroline Vandeputte et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Brain cannabinoid CB2 receptors modulate cocaine's actions in mice
Zheng-Xiong Xi et al.
NATURE NEUROSCIENCE (2011)
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
P. Pacher et al.
PROGRESS IN LIPID RESEARCH (2011)
Synthesis and biodistribution of [11C] A-836339, a new potential radioligand for PET imaging of cannabinoid type 2 receptors (CB2)
Andrew G. Horti et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Radiosynthesis of novel carbon-11-labeled triaryl ligands for cannabinoid-type 2 receptor
Masayuki Fujinaga et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2
R. G. Pertwee et al.
PHARMACOLOGICAL REVIEWS (2010)
Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity
Javier Palazuelos et al.
BRAIN (2009)
WIN55,212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease
David A. Price et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2009)
Cannabinoid CB2 Receptor Agonists Protect the Striatum Against Malonate Toxicity: Relevance for Huntington's Disease
Onintza Sagredo et al.
GLIA (2009)
Characterization of a Cannabinoid CB2 Receptor-Selective Agonist, A-836339 [2,2,3,3-Tetramethyl-cyclopropanecarboxylic Acid [3-(2-Methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide], Using in Vitro Pharmacological Assays, in Vivo Pain Models, and Pharmacological Magnetic Resonance Imaging
Betty B. Yao et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Synthesis and biological evaluation of carbon-11-and fluorine-18-labeled 2-oxoquinoline derivatives for type 2 cannabinoid receptor positron emission tomography imaging
Nele Evens et al.
NUCLEAR MEDICINE AND BIOLOGY (2009)
Cannabinoid CB2 receptors in human brain inflammation
C. Benito et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Immunohistochemical description of the endogenous cannabinoid system in the rat cerebellum and functionally related nuclei
Juan Suarez et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2008)
Labelling and biological evaluation of [11C]methoxy-Sch225336: a radioligand for the cannabinoide-type 2 receptor
Nele Evens et al.
NUCLEAR MEDICINE AND BIOLOGY (2008)
Brain Neuronal CB2 Cannabinoid Receptors in Drug Abuse and Depression: From Mice to Human Subjects
Emmanuel S. Onaivi et al.
PLOS ONE (2008)
Postsynaptic Localization of CB2 Cannabinoid Receptors in the Rat Hippocampus
Alicia Brusco et al.
SYNAPSE (2008)
Novel cannabinoid receptors
A. J. Brown
BRITISH JOURNAL OF PHARMACOLOGY (2007)
The CB2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset
Jennifer L. Shoemaker et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis
Cristina Benito et al.
JOURNAL OF NEUROSCIENCE (2007)
Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation
Javier Palazuelos et al.
FASEB JOURNAL (2006)
Characterization of peripheral human cannabinoid receptor (hCB2) expression and pharmacology using a novel radioligand, [35S]Sch225336
Waldemar Gonsiorek et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
AM1241, a cannabinoid CB2 receptor selective compound, delays disease progression in a mouse model of amyotrophic lateral sclerosis
Kathline Kim et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Expression of the cannabinoid CB2 receptor in the rat cerebellum: An immunohistochemical study
JC Ashton et al.
NEUROSCIENCE LETTERS (2006)
Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain
JP Gong et al.
BRAIN RESEARCH (2006)
Identification and functional characterization of brainstem cannabinoid CB2 receptors
MD Van Sickle et al.
SCIENCE (2005)
Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy
KJ Valenzano et al.
NEUROPHARMACOLOGY (2005)
Triaryl bis-sulfones as a new class of cannabinoid CB2 receptor inhibitors: identification of a lead and initial SAR studies
BJ Lavey et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Share Paper
